Kristian Reich, the Chief Scientific Officer of $MLTX, sold 50,000 shares of the company on 06-15-2026 for an estimated $944,500. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.7% of their shares of this class of stock. Following this trade, they now own 2,924,551 shares of this class of $MLTX stock.
$MLTX Insider Trading Activity
$MLTX insiders have traded $MLTX stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $MLTX stock by insiders over the last 6 months:
- KRISTIAN REICH (Chief Scientific Officer) has made 0 purchases and 3 sales selling 150,000 shares for an estimated $2,851,000.
- DA SILVA JORGE SANTOS (Chief Executive Officer) has made 0 purchases and 2 sales selling 150,000 shares for an estimated $2,752,162.
- MATTHIAS BODENSTEDT (Chief Financial Officer) has made 0 purchases and 4 sales selling 103,874 shares for an estimated $1,984,720.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$MLTX Hedge Fund Activity
We have seen 87 institutional investors add shares of $MLTX stock to their portfolio, and 99 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BVF INC/IL removed 3,750,000 shares (-19.0%) from their portfolio in Q1 2026, for an estimated $69,900,000
- D. E. SHAW & CO., INC. added 2,480,767 shares (+inf%) to their portfolio in Q4 2025, for an estimated $32,696,509
- JANUS HENDERSON GROUP PLC added 2,084,888 shares (+18782.8%) to their portfolio in Q4 2025, for an estimated $27,478,823
- AVORO CAPITAL ADVISORS LLC removed 2,000,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $26,360,000
- MPM BIOIMPACT LLC added 1,811,082 shares (+inf%) to their portfolio in Q1 2026, for an estimated $33,758,568
- DEEP TRACK CAPITAL, LP added 1,798,792 shares (+39.0%) to their portfolio in Q1 2026, for an estimated $33,529,482
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 1,500,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $27,960,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$MLTX Analyst Ratings
Wall Street analysts have issued reports on $MLTX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 06/08/2026
- BTIG issued a "Buy" rating on 02/23/2026
- Needham issued a "Buy" rating on 02/23/2026
- Goldman Sachs issued a "Sell" rating on 01/15/2026
To track analyst ratings and price targets for $MLTX, check out Quiver Quantitative's $MLTX forecast page.
$MLTX Price Targets
Multiple analysts have issued price targets for $MLTX recently. We have seen 9 analysts offer price targets for $MLTX in the last 6 months, with a median target of $30.0.
Here are some recent targets:
- Julian Harrison from BTIG set a target price of $30.0 on 06/09/2026
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $45.0 on 06/08/2026
- Serge Belanger from Needham set a target price of $30.0 on 05/12/2026
- Andy Chen from Wolfe Research set a target price of $24.0 on 03/23/2026
- Qize Ding from Rothschild & Co set a target price of $40.0 on 03/19/2026
- Kaveri Pohlman from Clear Street set a target price of $70.0 on 03/11/2026
- Brian Abrahams from RBC Capital set a target price of $13.0 on 03/02/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
